Qube Research & Technologies LTD Bioventus Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Bioventus Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 360,230 shares of BVS stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360,230
Previous 254,029
41.81%
Holding current value
$2.35 Million
Previous $2.67 Million
23.58%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BVS
# of Institutions
153Shares Held
47.7MCall Options Held
77.9KPut Options Held
39.3K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$84.8 Million34.4% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$45.2 Million27.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.13MShares$26.9 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$15.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $401M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...